Literature DB >> 19559959

Management of the N0 neck in moderately advanced squamous carcinoma of the larynx.

Fernando L Dias1, Roberto A Lima, Gabriel Manfro, Mauro M Barbosa, Scheilla Salviano, Ricardo M Rocha, Amanda S Marques, Cláudio R Cernea, Jacob Kligerman.   

Abstract

OBJECTIVE: To assess the oncological efficacy of selective neck dissection (SND) in patients with T3-4 N0 laryngeal squamous carcinoma. SUBJECTS AND METHODS: A total of 327 patients underwent 654 neck dissections; each side of the neck was individually evaluated.
RESULTS: Three percent of patients who had SND developed regional recurrence (RR) in comparison with 11.7 percent of patients who underwent modified radical neck dissection (MRND) (P=0.005). Only 3 (0.9%) patients developed RR outside the field of SND. The presence of extracapsular extension (P=0.002) in node-positive (pN+) group and of microvascular invasion (P=0.007), together with the type of neck dissection (ND) (P=0.0003) in node-negative (pN0) group had statistical impact on RR. The development of RR significantly affected disease-specific survival (P=0.0001). Equivalent rates of RR were found in pN+ (2.6%) or pN0 (3.2%) patients treated with SND (P=0.98) as well as in pN+ patients who underwent SND (2.6%) or MRND (4.7%) (P=0.85).
CONCLUSION: This study confirmed the adequacy of SND as a satisfactory staging and therapeutic procedure, and suggests its use in the treatment of limited node-positive (N+) neck.

Entities:  

Mesh:

Year:  2009        PMID: 19559959     DOI: 10.1016/j.otohns.2009.02.006

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

Review 1.  Superselective neck dissection: rationale, indications, and results.

Authors:  Carlos Suárez; Juan P Rodrigo; K Thomas Robbins; Vinidh Paleri; Carl E Silver; Alessandra Rinaldo; Jesus E Medina; Marc Hamoir; Alvaro Sanabria; Vanni Mondin; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-16       Impact factor: 2.503

2.  Cytokeratin immunohistochemically detected nodal micrometastases in N0 laryngeal cancer: impact on the overall occult metastases.

Authors:  Hesham Negm; Mohamed Mosleh; Hesham Fathy; Amal Hareedy; Ahmad Elbattawy
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-05       Impact factor: 2.503

3.  Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.

Authors:  Andrew C Birkeland; Andrew J Rosko; Mohamad R Issa; Andrew G Shuman; Mark E Prince; Gregory T Wolf; Carol R Bradford; Jonathan B McHugh; J Chad Brenner; Matthew E Spector
Journal:  Otolaryngol Head Neck Surg       Date:  2016-02-16       Impact factor: 3.497

4.  Predictive factors for pharyngocutaneous fistulization after total laryngectomy: a Dutch Head and Neck Society audit.

Authors:  Liset Lansaat; Vincent van der Noort; Simone E Bernard; Simone E J Eerenstein; Boudewijn E C Plaat; Ton A P M Langeveld; Martin Lacko; Frans J M Hilgers; Remco de Bree; Robert P Takes; Michiel W M van den Brekel
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-16       Impact factor: 2.503

5.  Malignant tumors of the larynx: Clinicopathologic profile and implication for late disease presentation.

Authors:  Ayotunde James Fasunla; Oluwole Agboola Ogundoyin; Paul Adekunle Onakoya; Onyekwere George Nwaorgu
Journal:  Niger Med J       Date:  2016 Sep-Oct

6.  Intra-Operative Lymphatic Mapping and Sentinel Node Biopsy in Laryngeal Carcinoma: Preliminary Results.

Authors:  Ehsan Khadivi; Maryam Daghighi; Kamran Khazaeni; Vahid Reza Dabbagh Kakhki; Leili Zarifmahmoudi; Ramin Sadeghi
Journal:  Iran J Otorhinolaryngol       Date:  2015-07

7.  Pre-Treatment Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Occult Cervical Metastasis in Clinically Negative Neck Supraglottic and Glottic Cancer.

Authors:  Giovanni Salzano; Francesco Perri; Fabio Maglitto; Giulia Togo; Gianluca Renato De Fazio; Michela Apolito; Federica Calabria; Claudia Laface; Luigi Angelo Vaira; Umberto Committeri; Mario Balia; Ettore Pavone; Corrado Aversa; Francesco Antonio Salzano; Vincenzo Abbate; Alessandro Ottaiano; Marco Cascella; Mariachiara Santorsola; Roberta Fusco; Luigi Califano; Franco Ionna
Journal:  J Pers Med       Date:  2021-11-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.